General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-08-10 | 2023-06 | -0.09 | N/A | N/A | N/A |
2023-05-15 | 2023-03 | -0.32 | N/A | N/A | N/A |
2023-03-30 | 2022-12 | -0.31 | N/A | N/A | N/A |
2022-11-14 | 2022-09 | -0.39 | N/A | N/A | N/A |
2022-08-11 | 2022-06 | -0.59 | N/A | N/A | N/A |
2022-05-16 | 2022-03 | -0.57 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-06-01 | Oppenheimer | Downgrade | Outperform | Perform |
2023-05-16 | Oppenheimer | Upgrade | Outperform | Outperform |
2023-03-31 | Cantor Fitzgerald | Upgrade | Overweight | |
2022-08-16 | HC Wainwright & Co. | Upgrade | Buy | |
2022-07-19 | Oppenheimer | Upgrade | Outperform | |
2021-09-24 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-06-06 | BIERMAN JAMES L | Director | 40.10K | Conversion of Exercise of derivative security |
2023-06-06 | GAY JOHN M. | Chief Financial Officer | 46.83K | Conversion of Exercise of derivative security |
2023-06-06 | GEER W KENT | Director | 37.68K | Conversion of Exercise of derivative security |
2023-06-06 | KEEGAN ROBERT J | Director | 42.40K | Conversion of Exercise of derivative security |
2019-07-01 | MALIN LIFE SCIENCES HOLDINGS, LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2019-05-28 | MARTIN G KELLY | Chief Executive Officer | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Armistice Capital, LLC | 2.25M | 1.26M | 8.02% |
2023-03-30 | Vanguard Group, Inc. (The) | 807.99K | 453.85K | 2.88% |
2023-03-30 | Blackrock Inc. | 302.31K | 169.81K | 1.08% |
2023-03-30 | B. Riley Wealth Advisors, Inc. | 187.00K | 105.04K | 0.67% |
2023-03-30 | Geode Capital Management, LLC | 150.45K | 84.51K | 0.54% |
2023-03-30 | Renaissance Technologies, LLC | 85.37K | 47.95K | 0.30% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | Vanguard Total Stock Market Index Fund | 545.36K | 306.33K | 1.95% |
2022-12-30 | Vanguard Extended Market Index Fund | 210.18K | 118.06K | 0.75% |
2023-02-27 | Fidelity Extended Market Index Fund | 81.81K | 45.95K | 0.29% |
2023-02-27 | iShares Micro Cap ETF | 41.29K | 23.19K | 0.15% |
2023-02-27 | Fidelity Series Total Market Index Fund | 27.73K | 15.58K | 0.10% |
2023-02-27 | Fidelity Total Market Index Fund | 20.46K | 11.49K | 0.07% |
Split | Date |
---|---|
1 : 10 | 2021-05-26 |
1 : 10 | 2021-05-25 |
Wall Down
In at .60 hope this fucker goes up
Some post level 2. Please
There it goes up again, very good
Never mind there are a lot of people who trust in that one
Ready steady go!!! Ruuuuuun!
Yesss!!! Great!! The one to choose in these days
https://clinicaltrials.gov/ct2/results?pg=1&load=cart&id=NCT04290871+OR+NCT04290858
Here’s an informative link on the rumoured treatment. Do your DD.
$NOVN I told you morning get NOVN
Someone post level 2
$NOVN Zacks strong buy now number one
Rise up!!!!